Aureon Biosciences Obtains $3,838,665 New Funding Round

  • Feed Type
  • Date
    9/30/2011
  • Company Name
    Aureon Biosciences
  • Mailing Address
    28 Wells Avenue Yonkers, NY 10701
  • Company Description
    Aureon Biosciences is a life science company founded in 2002, dedicated to enabling the advancement of predictive and personalized cancer treatment options.
  • Website
    http://www.aureon.com
  • Transaction Type
    Debt
  • Transaction Amount
    $3,838,665
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing-amended.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.

  • jim

    Aureon Biosciences just closed shop yesterday (10/04/2011) citing uncontrolled debt and inability to secure bridge loans from VC

  • Larry

    Did Aureon declare bankruptcy or just closed their doors? Am looking for a possible creditor list to be added to.